Elanco Releases 2022 Environmental, Social and Governance Report, Demonstrating Sustainability Progress in Internal Operations and Customer Collaborations
July 20 2023 - 08:00AM
Business Wire
Elanco Animal Health Incorporated (NYSE:ELAN) today released its
2022 Environmental, Social and Governance (ESG) Report highlighting
enhanced governance, transparency and progress measurements.
Elanco’s commitment to important ESG-related topics is
demonstrated across its four interconnected Healthy Purpose™
Pillars: Healthier Animals, Healthier People, Healthier Planet and
Healthier Enterprise. Through numerous internal initiatives and
external collaborations within each pillar, Elanco is working to
positively impact global concerns such as food security and
nutrition, human health and well-being, and environmental
sustainability.
“Healthy animals are essential for a healthy world. This belief
is embedded in our vision – Food and Companionship Enriching Life –
and is the anchor to Elanco's approach to ESG-related matters and
advancing our sustainability goals," said Jeff Simmons, President
and CEO Elanco. "This year's report includes examples of our impact
as a global organization. For instance, between 2020 and 2022,
we've helped beef and dairy customers avoid an estimated 7.2
million metric tons of CO2e emissions by using Rumensin™ – roughly
equivalent to taking 1.6 million1 passenger cars off the road for a
year. Additionally, through multiple logistics initiatives, in 2022
we reduced transportation and distribution emissions more than 10%
from the prior year.”
Along with this year’s report, the company introduced a
collection of supporting issue briefs containing meaningful
oversight and procedural disclosures for leading ESG issues and
enhanced performance metrics demonstrating Elanco’s ongoing
commitment to transparency.
Key highlights from Elanco’s 2022 ESG Report:
Healthier Animals: Helping pets and farm animals live
healthy, high-quality lives by continuously expanding our existing
portfolio while identifying new and innovative animal care
products, practices and services to support animal health and
well-being because making life better for animals makes life
better.
- Advanced four crucial innovations to improve the
quality-of-life of pets, through the U.S. launch of Zorbium® for
feline pain, Bexacat™ (bexagliflozin tablets) for feline diabetes,
as well as conditional FDA approval for Varenzin-CA1 (molidustat
oral suspension) for nonregenerative anemia in cats with chronic
kidney disease and a conditional USDA license for our Canine
Parvovirus Monoclonal Antibody.
- Conducted more than 400 training sessions for farmers and
ranchers, including topics such as animal care, management and
animal welfare.
- Managed several data platforms through Elanco Knowledge
Solutions (EKS) to help customers track leading livestock health
and quality indicators accounting for approximately 40% of the U.S.
beef industry, approximately 3% of U.S. dairy cows and more than
11,000 broiler farms globally.
Healthier People: Improving lives and livelihoods by
promoting animal companionship and enabling healthier and more
sustainable meat, milk, fish and egg production.
- Made progress combating antimicrobial resistance by receiving
approval for the salmonella vaccine AviPro™ Salmonella Duo in
Thailand.
- Supported small-scale livestock producers through our
shared-value initiatives by:
- Concluding the East Africa Growth Accelerator (EAGA)
initiative, supporting and enhancing the agricultural productivity
of more than 273,000 small-scale producers between 2017 and
2022.
- Launching the Managing Animal Health and Acaricides for a
Better Africa (MAHABA) initiative, a collaboration between Elanco
and The Global Alliance for Livestock Veterinary Medicine
(GALVmed), to provide training on tick-borne diseases, integrated
tick management and responsible use of acaricides to small-scale
cattle producers in Uganda and small-scale cattle and poultry
producers in Nigeria.
Healthier Planet: Minimizing the company’s environmental
footprint while leveraging product and service innovations to help
stakeholders advance their sustainability efforts.
- Expanded the reporting boundary for Scope 1 and 2 emissions to
include all sites for which Elanco has complete operational
control.
- Completed a comprehensive analysis of 2021 and 2022 Scope 3
greenhouse gas (GHG) emissions and commenced reporting.
- Sourced approximately 12% of electricity from renewable sources
in 2022, delivering significant progress on the company’s goal of
100% renewable electricity by 2030.
- Supported reduced customer emissions in livestock production:
- Helped customers collectively avoid an estimated 7.2 million
metric tons of CO2e emissions through the use of Rumensin between
2020 and 2022 – approximately 33% attainment toward a goal to help
Elanco customers avoid 21 million metric tons of GHG emissions from
their farms by 2030.
- Established a partnership with DSM for exclusive rights to
manufacture and sell Bovaer® in the U.S., a product to reduce
enteric methane emissions by approximately 30% for dairy cows and
even higher percentages for beef cattle. Elanco continues to have a
path toward FDA authorization in the first half of 2024.
Healthier Enterprise: Growing Elanco’s business with
integrity and excellence with respect for all stakeholders,
fostering an inclusive culture where employees can make a
difference – encouraging ownership, growth and well-being.
- Advanced diversity, equity and inclusion strategy, programs and
expectations, including:
- Increased representation of women in leadership globally to
35.8% at the end of 2022.
- Increased representation of People of Color in U.S. leadership
to 17.4% at the end of 2022.
- Achieved approximately 20% employee participation in at least
one Employee Resource Group (ERG).
- Supported local communities with more than 12,800 documented
hours of employee volunteerism benefitting causes worldwide, valued
at approximately $400K.
- Donated more than $4M in combined corporate, foundation and
employee charitable and community giving – benefiting more than 350
community organizations.
For details on the company’s ESG disclosures, policies, programs
and initiatives, visit elanco.com/en-us/sustainability.
ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global
leader in animal health dedicated to innovating and delivering
products and services to prevent and treat disease in farm animals
and pets, creating value for farmers, pet owners, veterinarians,
stakeholders and society as a whole. With nearly 70 years of animal
health heritage, we are committed to helping our customers improve
the health of animals in their care, while also making a meaningful
impact on our local and global communities. At Elanco, we are
driven by our vision of Food and Companionship Enriching Life and
our Elanco Healthy Purpose– all to advance the health of animals,
people, the planet and our enterprise. Learn more at
www.elanco.com
1 Estimated equivalency calculated via the U.S. EPA Greenhouse
Gas Equivalencies Calculator, Greenhouse Gas Equivalencies
Calculator | US EPA
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230720143219/en/
Investor Contact Kathryn Grissom +1.317.273.9284
kathryn.grissom@elancoah.com
Media Contact Colleen Parr Dekker +1.317.989.7011
colleen.dekker@elancoah.com
Elanco Animal Health (NYSE:ELAN)
Historical Stock Chart
From Nov 2023 to Dec 2023
Elanco Animal Health (NYSE:ELAN)
Historical Stock Chart
From Dec 2022 to Dec 2023